Short Interest in Sonova Holding (OTCMKTS:SONVY) Rises By 426.1%

Sonova Holding (OTCMKTS:SONVY) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 11,510 shares, a growth of 426.1% from the December 15th total of 2,188 shares. Based on an average daily volume of 52,730 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the shares of the stock are short sold. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 52,730 shares, the days-to-cover ratio is presently 0.2 days.

Sonova Stock Up 3.8%

Shares of Sonova stock opened at $55.35 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.91 and a current ratio of 1.24. The business has a 50-day moving average of $51.35 and a two-hundred day moving average of $55.03. Sonova has a 1 year low of $47.55 and a 1 year high of $71.50.

Analysts Set New Price Targets

Several research firms have recently commented on SONVY. Rothschild Redb upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. BNP Paribas began coverage on shares of Sonova in a report on Monday, October 20th. They set an “underperform” rating for the company. Royal Bank Of Canada upgraded shares of Sonova to a “moderate buy” rating in a research report on Tuesday, November 18th. Finally, Zacks Research lowered Sonova from a “hold” rating to a “strong sell” rating in a research report on Tuesday, December 9th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold”.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.